# Princeton Biopharma Capital Partners

> Princeton Biopharma Capital Partners is a VC fund backing Health Care. See 4 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 4
- Last investment: Jul 2021
- Lead investor: 25%
- Last updated: Sep 2026
- Website: http://www.princetonbcp.com

Princeton Biopharma Capital Partners is a VC fund in New York focused on Health Care and Medical Device. Princeton Biopharma Capital Partners, LLC is a private equity investment firm focused on investing in commercial stage healthcare companies. Our target investments include start-ups being formed around carve-outs and existing companies in need of growth capital or restructuring. Our principals have extensive track records as operators inhealthcare, therefore we prefer to focus on opportunities where we can add value in addition to a capital commitment. Our investment team follows a careful, proven process that begins with the identification of underutilized assets with unrealized potential. At Princeton Biopharma Capital Partners we can leverage our capital and operating experience to work with management teams to unlock value, grow their companies and position them for a range of future strategic options.

## Contacts

5 contacts available for Princeton Biopharma Capital Partners. Shizune tracks 1 team members at Princeton Biopharma Capital Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/princeton-biopharma-capital-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| Medical Device | 2 | 50% |
| Veterinary | 1 | 25% |
| Biotechnology | 1 | 25% |
| Pharmaceutical | 1 | 25% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 25% |
| Series A | 1 | 25% |
| Debt Financing | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Michael Wells | Founder & Managing Director | 3 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Fidelis Pharmaceuticals | Fidelis Pharmaceuticals offers exceptional expertise in the acquisition, development, and marketing of unique pharmaceutical formulations that meet specialized veterinary needs. Fidelis Pharmaceuticals is a privately held U.S.-based company serving the world from the Northeast pharmaceutical corridor. The company is headquartered in NorthBrunswick, New Jersey. | $5.1M | Venture - Series Unknown | Jul 21, 2021 | https://fidelisrx.com/ |
| ActiveProtective | ActiveProtective is a consumer device company that produces smart garments to reduce traumatic injury using wearable airbag technology. The company's proprietary technology uses 3D motion sensors to determine the stereotypical motions and accelerations that govern the body’s normal, daily activities, in order to determine ’departures’ fromwhat is allowable.This technique called "fall disambiguation", allows users to determine falls prior to impact, intercept hip fractures, and protect themselves from risks during sports and military sessions by deploying micro-airbag protection.ActiveProtective was founded in 2006 and is based in Allentown, Pennsylvania. | $1M | Series A | Jan 03, 2018 | http://www.activeprotective.com/ |
| ActiveProtective | ActiveProtective is a consumer device company that produces smart garments to reduce traumatic injury using wearable airbag technology. The company's proprietary technology uses 3D motion sensors to determine the stereotypical motions and accelerations that govern the body’s normal, daily activities, in order to determine ’departures’ fromwhat is allowable.This technique called "fall disambiguation", allows users to determine falls prior to impact, intercept hip fractures, and protect themselves from risks during sports and military sessions by deploying micro-airbag protection.ActiveProtective was founded in 2006 and is based in Allentown, Pennsylvania. | $2.6M | Seed | Nov 22, 2016 | http://www.activeprotective.com/ |
| Photosonix Medical | Photosonix Medical develops CLENS™ (Coincident Light Energy and Non-focused ultraSound), an energy-based therapy which synergistically combines light and ultrasound to treat chronic bacterial infections known as biofilms. The company targets dermal diseases, specifically moderate to severe acne. Its target prescribers include dermatologists andprimary care physicians.Photosonix Medical is based in Ambler, Pennsylvania. | $1.7M | Debt Financing | May 13, 2016 | http://www.photosonixmed.com |

4 of 4 investments shown.

## Co-investors
- Key Safety Systems — VC Fund, 2 deals together
- [Leading Edge Ventures](https://shizune.co/investors/profile/leading-edge-ventures) — VC Fund, 2 deals together
- Aging2.0 — VC Fund, 1 deal together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together
- Generator Fund — VC Fund, 1 deal together
- [New York Angels](https://shizune.co/investors/profile/new-york-angels) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Princeton Biopharma Capital Partners invest in?

Princeton Biopharma Capital Partners invests primarily in Health Care, Medical Device and Veterinary startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Princeton Biopharma Capital Partners?

Public channels for Princeton Biopharma Capital Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Princeton Biopharma Capital Partners?

The team at Princeton Biopharma Capital Partners includes Michael Wells (Founder & Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co